The mission of the University of Arizona Cancer Center Biorepository is to provide high quality cancer and related tissue as well as body fluids to our collaborators. The Biorepository contains tissue that has been preserved by snap freezing in OCT embedding media, snap frozen tissue in vials, as well as formalin-fixed, paraffin embedded (FFPE) tissue. Body fluids include whole blood, serum, plasma and urine. All samples have been de-identified, are reviewed for quality control by a pathologist, have associated clinico-pathologic data and the information is entered into the HIPPA compliant biospecimen software application, Tissue Metrix.
The use of the tissue and biospecimens from the Repository is available to UACC members and collaborating investigators. First, compliance with the University of Arizona Institutional Review Board (IRB) policies and approval requirements must be documented. Next investigators will then submit the proposal to TACMASR documenting the objectives of their study, preliminary data supporting their hypothesis, their research plan, and expected outcome. TACMASR will submit the proposal to the Biospecimen Oversight Committee for final approval. Dr. Setsuko Chambers is the chair of this committee and the PI of the UACC Biorepository.
Contributing surgeons have the right of first refusal for the use of the specimens which they or their team have contributed from their patients. They will be contacted by the Biorepository Staff prior to consideration of release of any of their specimens.
For further information please contact us.
Everyone involved in submitting specimens to the Tumor Bank must maintain a current CITI Certification. For more information read about the CITI Certification Program.